Skip to main content
. 2020 Sep 11;42(6):998–1004. doi: 10.1038/s41401-020-00513-3

Table 1.

Biochemical activities (IC50, Mean ± SD, nM) of ROS1 inhibitors and SAF-189s.

Kinase SAF-189s Crizotinib Ceritinib Lorlatinib
ROS1 0.5 ± 0.1 1.5 ± 0.2 2.7 ± 0.8 0.3 ± 0.2
ROS1G2032R 12.4 ± 5.4 222.5 ± 55.2 271.4 ± 82.8 17.3 ± 3.7
ROS1L2026M 0.2 ± 0.2 9.8 ± 1.3 2.6 ± 0.2 2.4 ± 0.1
ROS1S1986F 0.7 ± 0.4 3.1 ± 0.9 3.7 ± 1.1 0.4 ± 0.2
ROS1S1986Y 0.3 ± 0.3 2.9 ± 0.7 5.7 ± 1.4 0.4 ± 0.3
ROS1D2033N 2.9 ± 0.9 20.2 ± 3.3 24.0 ± 2.5 2.2 ± 0.3